- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.74 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 7YE: N-[4-[(5R)-6-oxidanylidene-5-quinolin-5-yl-5-(trifluoromethyl)-1,4-dihydropyridazin-3-yl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-2-carboxamide(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.2: 5 residues within 4Å:- Chain A: R.41, R.393, S.399, K.401, K.416
20 PLIP interactions:16 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:S.399
- Water bridges: A:R.393, A:R.393, A:N.397, A:C.398, A:F.400, A:K.401, A:K.401, A:K.401, A:K.416, A:K.424, A:K.424, B:D.314, B:D.314, B:D.355, B:D.355
- Salt bridges: A:R.41, A:R.393, A:K.401, A:K.416
PO4.3: 7 residues within 4Å:- Chain A: R.197, E.247, H.248, R.312, D.314
- Chain B: Y.19
- Ligands: 7YE.1
17 PLIP interactions:11 interactions with chain A, 6 interactions with chain B- Hydrogen bonds: A:H.248, B:Y.19, B:Y.19
- Water bridges: A:R.197, A:R.197, A:R.197, A:E.247, A:S.249, A:R.312, A:R.312, B:K.401, B:K.401, B:K.401
- Salt bridges: A:R.197, A:H.248, A:R.312, B:K.401
PO4.7: 5 residues within 4Å:- Chain B: R.41, R.393, S.399, K.401, K.416
22 PLIP interactions:5 interactions with chain A, 17 interactions with chain B- Water bridges: A:D.314, A:D.314, A:D.355, A:D.355, A:D.355, B:R.393, B:R.393, B:R.393, B:F.400, B:K.401, B:K.401, B:K.416, B:K.424, B:K.424
- Hydrogen bonds: B:S.399, B:S.399, B:S.399
- Salt bridges: B:R.41, B:R.393, B:K.401, B:K.416, B:K.424
PO4.8: 7 residues within 4Å:- Chain A: Y.19
- Chain B: R.197, E.247, H.248, R.312, D.314
- Ligands: 7YE.6
14 PLIP interactions:9 interactions with chain B, 5 interactions with chain A- Hydrogen bonds: B:H.248, A:Y.19
- Water bridges: B:R.197, B:R.197, B:E.247, B:S.249, B:R.312, A:Y.19, A:K.401, A:K.401, A:K.401
- Salt bridges: B:R.197, B:H.248, B:R.312
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 6 residues within 4Å:- Chain A: G.123, F.124, V.125, R.435, F.441, N.480
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:V.125, A:R.435, A:R.435
GOL.5: 6 residues within 4Å:- Chain A: G.354, D.355, G.356, G.384, G.385
- Chain B: R.393
12 PLIP interactions:9 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:D.355, A:G.356, A:G.384, A:G.385, B:R.393
- Water bridges: A:G.354, A:D.355, A:D.355, A:V.357, A:V.357, B:R.393, B:R.393
GOL.9: 5 residues within 4Å:- Chain B: G.123, F.124, V.125, R.435, N.480
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:V.125, B:R.435, B:R.435, B:N.480
GOL.10: 6 residues within 4Å:- Chain A: R.393
- Chain B: G.354, D.355, G.356, G.384, G.385
8 PLIP interactions:5 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:G.354, B:G.356, B:G.384, B:G.385, A:R.393
- Water bridges: B:V.357, A:R.393, A:D.394
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bohnke, N. et al., A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer Therapy. Bioconjug.Chem. (2022)
- Release Date
- 2022-06-15
- Peptides
- Nicotinamide phosphoribosyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.74 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 7YE: N-[4-[(5R)-6-oxidanylidene-5-quinolin-5-yl-5-(trifluoromethyl)-1,4-dihydropyridazin-3-yl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-2-carboxamide(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bohnke, N. et al., A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer Therapy. Bioconjug.Chem. (2022)
- Release Date
- 2022-06-15
- Peptides
- Nicotinamide phosphoribosyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B